TD Cowen analyst Yaron Werber raised the firm’s price target on BeiGene to $224 from $222 and keeps an Outperform rating on the shares. The firm updated their mode to account for the latest NRDL negotiations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BGNE:
